Gelesis (PTCHF) Expects Data Readout in First Half of 2017 of 3 Month Proof-of-Concept Trial Evaluating Gelesis200 in Glycemic Control and Weight Loss in Prediabetic & Type 2 Diabetic Patients
- Source Link:
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Don’t see a project related to the catalyst you care about?